Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.


Journal

The American Journal of dermatopathology
ISSN: 1533-0311
Titre abrégé: Am J Dermatopathol
Pays: United States
ID NLM: 7911005

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 23 6 2020
medline: 29 9 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Deep penetrating nevus (DPN) is an intradermal, sometimes compound benign melanocytic lesion, which involves the reticular dermis, occasionally reaching the subcutis, which can raise concern for melanoma both clinically and histologically. Recently, it has been genetically defined by the combination of MAPK activating and β-catenin activating mutations. We sought to investigate genetic alterations in 2 cases of combined nevi of congenital melanocytic and DPN. Case 1 was a 16-year-old woman with a pigmented lesion on the trunk since birth, which was completely excised. Histopathological examination revealed a combined congenital nevus with a DPN. Comparative genomic hybridization showed no major genetic alterations, except for gain of 6q11.1 and point mutation of B-RAF V600E. Case 2 was a 62-year-old woman with a congenital pigmented lesion on the back. The lesion was diagnosed as a combined nevus of congenital and DPN. Comparative genomic hybridization showed no genetic alterations, and the NRAS Q61K was detected in both components. DPN is in most cases part of a combined nevus. Our cases showed strong and uniform nuclear expression of β-catenin and cyclin D1 in the DPN component suggesting the evolution of the congenital nevus to the DPN clone by acquiring β-catenin activating mutation.

Identifiants

pubmed: 32568834
doi: 10.1097/DAD.0000000000001704
pii: 00000372-202012000-00007
doi:

Substances chimiques

Biomarkers, Tumor 0
CCND1 protein, human 0
CTNNB1 protein, human 0
Membrane Proteins 0
beta Catenin 0
Cyclin D1 136601-57-5
BRAF protein, human EC 2.7.11.1
Proto-Oncogene Proteins B-raf EC 2.7.11.1
GTP Phosphohydrolases EC 3.6.1.-
NRAS protein, human EC 3.6.1.-

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

948-952

Références

Seab JA, Graham JH, Helwig EB. Deep penetrating nevus. Am J SurgPathol. 1989;13:39–44.
Barnhill RL, Mihm MC Jr, Magro CM. Plexiform spindle cell nevus; a distinct variant of plexiform melanocytic nevus. Histopathology. 1991;18:243–247.
Cooper PH. Deep penetrating (plexiform spindle cell) nevus: a frequent participant in combined nevus. J Cutan Pathol. 1992;19:172–180.
Robson A, Morley-Quante M, Hempel H, et al. Deep penetrating nevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology. 2003;43:529–537.
Yeh I, Lang UE, Durieux E, et al. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi. Nat Commun. 2017;8:644.
Sunassee A, Kerkvliet AM, Jassim AD. Combined melanocytic nevus, superficial congenital and deep penetrating types with fibroepithelioma of pinkus, collision tumor—a case report. S D Med. 2017;70:363–365.
Almodovar-Real A, Molina-Leyva A, Aneiros-Fernandez J. Proliferative nodule in melanocytic nevi mimicking deep penetrating nevus. Bras Dermatol. 2017;92:231–233.
Leboit PE, Massi G. Histological Diagnosis of Nevi and Melanoma. Würzburg, Germany: Spinger Ed; 2004.
Salgado C, Basu D, Nikiforova M, et al. BRAF mutations are also associated with neurocutaneousmelanocytosis and large/giant congenital melanocytic nevi. Pediatr Develop Pathol. 2015;18:1–9.
Phadke PA, Rakheja D, Le LP, et al. Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical and molecular analyses of 43 cases. Am J Surg Pathol. 2011;33:341–344.
Leech S, Bell H, Leonard N, et al. Neonatal giant congenital nevi with proliferative nodules: a clinicopathologic study and literature review of neonatal melanoma. Arch Dermatol. 2004;140:83–88.
Bauer J, Bastian B. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther. 2006;19:40–49.
Bastian B, Xiong J, Frieden I, et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol. 2002;161:1163–1169.

Auteurs

Maria C Garrido (MC)

Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación I+12, Madrid, Spain.

Laura Nájera (L)

Department of Pathology, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Antonia Navarro (A)

Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Victoria Huerta (V)

Department of Pathology, Hospital Santa Caterina, Girona, Spain; and.

Enrique Garrido (E)

Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación I+12, Madrid, Spain.

Jose-Luis Rodriguez-Peralto (JL)

Department of Pathology, Hospital Universitario 12 de Octubre, Universidad Complutense, Instituto de Investigación I+12, Madrid, Spain.

Luis Requena (L)

Department of Dermatology, Fundación Jimenez-Diaz, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH